Shara Dawn Rice

Title: Shara Dawn Rice: Innovator in Chemo-sensitivity Assays

Introduction

Shara Dawn Rice is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical technology, particularly in the development of chemo-sensitivity assays. With a total of 2 patents, his work focuses on improving cancer treatment methodologies.

Latest Patents

Shara's latest patents include innovative assays that utilize tumor cells exhibiting persistent phenotypic characteristics. These assays represent an improved and unified system for monitoring the progression of individual patient malignancies. They are designed to identify cellular and secreted markers, screen cells for phenotypic and genotypic drift, and predict the chemotherapeutic response of patient tumor cells to various therapeutic agents. Additionally, these systems allow for the monitoring and screening of multiple pharmaceutical agents for efficacy and long-term effects tailored to specific patients.

Career Highlights

Shara Dawn Rice is currently associated with Precision Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in enhancing the understanding of cancer treatment responses, which can lead to more personalized and effective therapies for patients.

Collaborations

Some of Shara's notable coworkers include Michael J. Gabrin and Stacey Brower. Their collaborative efforts contribute to the innovative environment at Precision Therapeutics, Inc., fostering advancements in cancer treatment technologies.

Conclusion

Shara Dawn Rice's contributions to the field of chemo-sensitivity assays highlight his commitment to improving cancer treatment methodologies. His innovative work continues to pave the way for advancements in personalized medicine, ultimately benefiting patients facing malignancies.